{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:13:06Z","timestamp":1782493986411,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.radonc.2025.110911","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:19:15Z","timestamp":1745749155000},"page":"110911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy"],"prefix":"10.1016","volume":"208","author":[{"given":"Jenna","family":"Rocchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Yegya-Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Iocolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3047-3151","authenticated-orcid":false,"given":"Jeffrey","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Feigenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-889X","authenticated-orcid":false,"given":"Cole","family":"Friedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110911_b0005","series-title":"Lung Cancer","author":"Siddiqui","year":"2025"},{"key":"10.1016\/j.radonc.2025.110911_b0010","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians 2024;74:12\u201349. Doi: 10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"10.1016\/j.radonc.2025.110911_b0015","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.110911_b0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.radonc.2025.110911_b0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ijrobp.2023.10.005","article-title":"Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors","volume":"118","author":"Friedes","year":"2024","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110911_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jrr\/rrac057","article-title":"Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer","volume":"64","author":"Kishi","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2025.110911_b0040","first-page":"22","volume":"01","year":"2025","journal-title":"(Accessed"},{"key":"10.1016\/j.radonc.2025.110911_b0045","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/cancers16213587","article-title":"Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer","volume":"16","author":"Ning","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.110911_b0050","article-title":"Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era. Front","volume":"12","author":"Janopaul-Naylor","year":"2023","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0055","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/1759-7714.13884","article-title":"Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single\u2010center retrospective analysis","volume":"12","author":"Grambozov","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.radonc.2025.110911_b0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0360-3016(01)02644-X","article-title":"Reirradiation for locally recurrent lung cancer previously treated with radiation therapy","volume":"52","author":"Okamoto","year":"2002","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110911_b0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2013.08.014","article-title":"Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer","volume":"109","author":"McAvoy","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2014.07.030","article-title":"Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes","volume":"90","author":"McAvoy","year":"2014","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110911_b0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtho.2016.10.018","article-title":"Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non\u2013Small Cell Lung Cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0080","first-page":"76","article-title":"Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer","volume":"22","author":"Yang","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/life12020292","article-title":"Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.radonc.2025.110911_b0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.prro.2017.07.002","article-title":"Reirradiation of thoracic cancers with intensity modulated proton therapy","volume":"8","author":"Ho","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.prro.2019.02.008","article-title":"Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies","volume":"9","author":"Badiyan","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2023.08.047","article-title":"Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer","volume":"119","author":"Yegya-Raman","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110911_b0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3857\/roj.2020.01074","article-title":"Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer","volume":"39","author":"Shin","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2025.110911_b0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","article-title":"Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment","volume":"110","author":"Kilburn","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-8-99","article-title":"Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)","volume":"8","author":"Reyngold","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-019-5542-3","article-title":"Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer","volume":"19","author":"Sumodhee","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.110911_b0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00066-019-01457-2","article-title":"Re-irradiation in locally recurrent lung cancer patients","volume":"195","author":"Schlampp","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110911_b0130","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110911_b0135","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE v5.0). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_r eference_5x7.pdf (Accessed 01.23.2025)."},{"key":"10.1016\/j.radonc.2025.110911_b0140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12885-020-06843-z","article-title":"Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact","volume":"20","author":"Hazell","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.110911_b0145","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/cncr.35230","article-title":"Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non\u2013small cell lung cancer in the durvalumab era","volume":"130","author":"Iocolano","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110911_b0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1759-7714.13764","article-title":"Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone","volume":"12","author":"Abe","year":"2021","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.radonc.2025.110911_b0155","doi-asserted-by":"crossref","unstructured":"Bradley JD, Nishio M, Okamoto I, Newton MD, Trani L, Shire NJ, et al. PACIFIC-2: Phase 3 study of concurrent durvalumab and platinum-based chemoradiotherapy in patients with unresectable, stage III NSCLC. JCO 2019;37:TPS8573\u2013TPS8573. Doi: 10.1200\/JCO.2019.37.15_suppl.TPS8573.","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS8573"},{"key":"10.1016\/j.radonc.2025.110911_b0160","doi-asserted-by":"crossref","unstructured":"Spigel DR, Cheng Y, Cho BC, Laktionov KK, Fang J, Chen Y, et al. ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC). JCO 2024;42:LBA5\u2013LBA5. Doi: 10.1200\/JCO.2024.42.17_suppl.LBA5.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5"},{"key":"10.1016\/j.radonc.2025.110911_b0165","doi-asserted-by":"crossref","unstructured":"Ross HJ, Hu C, Higgins KA, Jabbour SK, Kozono DE, Owonikoko TK, et al. NRG Oncology\/Alliance LU005: A phase II\/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. JCO 2020;38:TPS9082\u2013TPS9082. Doi: 10.1200\/JCO.2020.38.15_suppl.TPS9082.","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS9082"},{"key":"10.1016\/j.radonc.2025.110911_b0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.radonc.2025.110911_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg0117","article-title":"Sequence of \u03b1PD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses","volume":"6","author":"Wei","year":"2021","journal-title":"Sci Immunol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:58:06Z","timestamp":1753775886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"alternative-id":["S0167814025002063"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110911","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110911"}}